Flare Therapeutics: Valuation, Funding & Investors
Flare Therapeutics is a clinical-stage biotechnology company focused on discovering and developing precision medicines by targeting transcription factors and other historically undruggable proteins. The company leverages an integrated discovery platform to identify novel, validated ligands against the undrugged proteome, with an initial focus on oncology and expansion into other therapeutic areas.
Leadership & Board
- Current Number of Employees
- 49
- Current LinkedIn Followers
- 8,341
Latest Estimated Valuation
- Total Amount Raised
- $85M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $85M
- Latest Funding Round
- Series C
Employee Trend
Flare Therapeutics had 49 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Flare Therapeutics had 8,341 followers as of November 16, 2026. The number of followers increased by 21 (0.25%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jul 03, 2026 | Series C | $85.00M | ― |
Similar Companies
A snapshot of private companies similar to Flare Therapeutics, helping you discover and navigate related company profiles.
Related News and Analysis







